Abstract:
Background and Objectives: Robotics is commonly used in the rehabilitation of neuro-musculoskeletal injuries and diseases. While in these conditions, robotics has clear benefits, it is unknown whether robotics will also enhance the outcome of cardiac rehabilitation. This systematic review evaluates the use of robotics in cardiac rehabilitation. Methods: A systematic literature search was conducted using PubMed (MEDLINE), CINAHL, AMED, SPORTDiscus, and the Physiotherapy Evidence Database. Longitudinal interventional studies were included if they met specified criteria. Two reviewers independently conducted title, abstract, and full-text screening and data extraction. The quality assessment and risk of bias were conducted according to the PEDRO scale and Cochrane Risk of Bias tool 2, respectively. Results: Four trials were included in this review out of 60 screened studies. The quality of the included studies was good with a low risk of bias. The trials used different robotic systems: Lokomat® system, Motomed Letto/Thera Trainer tigo, BEAR, and Myosuit. It was found that interventions that included the use of robotic assistance technologies improved the exercise capacity, VO2 max/peak, left ventricular ejection fraction, QOL, and physical functioning in people with cardiac diseases. Conclusions: Robotic assistance technologies can be used in cardiac rehabilitation programs. Further studies are needed to confirm the results and determine whether the use of robotics enhances intervention outcomes above standard interventions.
摘要:
背景与目的:机器人技术常用于神经肌肉骨骼损伤和疾病的康复。在这些条件下,机器人有明显的好处,目前尚不清楚机器人技术是否也会提高心脏康复的效果。本系统综述评估了机器人技术在心脏康复中的应用。方法:使用PubMed(MEDLINE)进行系统的文献检索,CINAHL,AMED,SPORTDiscus,和物理治疗证据数据库。如果纵向介入研究符合特定标准,则将其纳入。两名审稿人独立进行标题,abstract,以及全文筛选和数据提取。分别根据PEDRO量表和Cochrane偏差风险工具2进行质量评估和偏差风险。结果:在60项筛选研究中,有4项试验被纳入本综述。纳入研究的质量良好,偏倚风险低。试验使用了不同的机器人系统:Lokomat®系统,MotomedLetto/TheraTrainertigo,熊,还有Myosit.研究发现,包括使用机器人辅助技术在内的干预措施提高了运动能力,VO2最大值/峰值,左心室射血分数,QOL,和心脏疾病患者的身体机能。结论:机器人辅助技术可用于心脏康复计划。需要进一步的研究来确认结果,并确定机器人的使用是否可以提高标准干预措施的干预效果。